Rubella virus - medicine shortage information
Back to ALL shortages and discontinuations Back to CRITICAL shortages and discontinuations
If you are having difficulty obtaining a medicine that has been prescribed to you, talk to your doctor or pharmacist to discuss suitable options to continue your care.
More information about medicine shortages and how to access alternative medicines is available at the Medicine Shortages hub
| Product details |
Supply Impact Dates |
Further Details |
PRIORIX ALBUMIN FREE VACCINE 0.5mL powder for injection vial and diluent syringe AUST R: 97842Active ingredients:
Measles virus
Mumps virus
Rubella virus
Dosage form:
Injection, powder for
Sponsor:
GlaxoSmithKline Australia Pty Ltd
Phone:
1800033109
|
From
20 Jun 2025
to
30 Sep 2025
|
Shortage status:
Current
Availability:
Limited Availability
Reason:
Unexpected increase in consumer demand
Management action:
The sponsor is closely controlling the supply. This shortage is applicable to the private market for this product. There is no impact on the government or NIP supply.
|
PRIORIX-TETRA vaccine 0.5mL powder for injection vial with diluent syringe AUST R: 107286Active ingredients:
live varicella vaccine
Measles virus
Mumps virus
Rubella virus
Dosage form:
Injection, powder for
Sponsor:
GlaxoSmithKline Australia Pty Ltd
Phone:
1800033109
|
From
01 Jul 2025
to
15 Jul 2025
|
Shortage status:
Current
Availability:
Unavailable
Reason:
Manufacturing
Management action:
This shortage is only applicable to the private market. There is no impact on the government or NIP supply.
|